Success stories September 19, 2024 / News Sooma Partners with JSTT to Introduce Brain Stimulation Treatments in Occupational Healthcare Read more August 19, 2024 / News Prioritizing Youth Mental Health: A Call to Action Read more March 12, 2024 / News Sooma Secures €5M Funding for At-home Brain Stimulation Therapies Read more February 6, 2024 / News Release Notes for Sooma Duo App and Portal Software Version 1.2.3 Read more December 20, 2023 / News Reflecting on a Year of Innovation and Achievement: Sooma in 2023 Read more October 26, 2023 / News Sooma launches system for remote clinician-monitored brain stimulation Read more September 15, 2023 / News Sooma becomes the first tDCS device manufacturer to receive European MDR certification Read more June 14, 2023 / News Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment Read more June 8, 2023 / News Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio Read more March 6, 2023 / News FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device Read more Show all articles
September 19, 2024 / News Sooma Partners with JSTT to Introduce Brain Stimulation Treatments in Occupational Healthcare Read more
October 26, 2023 / News Sooma launches system for remote clinician-monitored brain stimulation Read more
September 15, 2023 / News Sooma becomes the first tDCS device manufacturer to receive European MDR certification Read more
June 14, 2023 / News Open-Label Study Highlights Efficacy of Sooma Depression Therapy for MDD Treatment Read more
June 8, 2023 / News Sooma Receives Intention to Grant Patent from EPO for Its Innovative Electrode Placement System, Reinforcing Patent Portfolio Read more
March 6, 2023 / News FDA Breakthrough Device Designation granted to Sooma for Its Innovative At-Home Depression Treatment Device Read more